In consultation: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442] | Draft guidance | Technology appraisal guidance | |
| Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis [ID6487] | Draft guidance | Technology appraisal guidance |